Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Lansing
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lansing, MI

Studies commonly pay $75 to $4,500 per completed study

185 clinical trials are currently recruiting participants within 30 miles of Lansing. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

185studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Lansing right now

Top 25 of 185 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Active Rheumatoid Arthritis Phase 2 Interventional 180 participants sought
Great Lakes Center of Rheumatology — Lansing, Michigan (1.3 mi) · Sponsor: Elevara Medicines Limited
See eligibility & contact on ClinicalTrials.gov (NCT07409103)

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

Multiple Myeloma Phase 2 Interventional 60 participants sought
KCI at McLaren Greater Lansing — Lansing, Michigan (1.3 mi) · Sponsor: Barbara Ann Karmanos Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT06107738)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 380 participants sought
Barbara Ann Karmanos Cancer Institute - McLaren Greater Lansing /ID# 259891 — Lansing, Michigan (1.3 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06158841)

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

Narcolepsy Type 1 Phase 3 Interventional 150 participants sought
Alkermes Investigational Site — Lansing, Michigan (1.3 mi) · Sponsor: Alkermes, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07540897)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures

Wound Closure, Brain Tumor Adult Phase 4 Interventional 160 participants sought
University of Michigan Health Sparrow — Lansing, Michigan (1.3 mi) · Sponsor: University of Michigan
See eligibility & contact on ClinicalTrials.gov (NCT07225101)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Breast Cancer, Early Breast Cancer Phase 3 Interventional 4,300 participants sought
Research Site — Lansing, Michigan (1.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05774951)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 2 Interventional 405 participants sought
June DO, PC — Lansing, Michigan (1.3 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07409181)

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 4 Interventional 350 participants sought
GSK Investigational Site — Lansing, Michigan (1.3 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT06411249)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05235165)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632977)

Treating Chronic Cervicogenic Head and Neck Pain

Cervicogenic Headache, Neck Pain, Posterior Phase 1, Phase 2 Interventional 30 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi) · Sponsor: Michigan State University
See eligibility & contact on ClinicalTrials.gov (NCT05617365)

Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections

Periprosthetic Joint Infection Phase 2 Interventional 60 participants sought
University of Michigan Health - Sparrow Clinical Research Institute — Lansing, Michigan (1.3 mi) · Sponsor: OsteoRemedies, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06428448)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT06592924)

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Psoriatic Arthritis, Axial Spondyloarthritis Phase 1 Interventional 392 participants sought
Pa0019 134 — Lansing, Michigan (1.3 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT07290036)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

Diabetes, End Stage Renal Disease N/A Interventional 304 participants sought
MSU Health Care Heart and Vascular — Lansing, Michigan (1.3 mi) · Sponsor: Sonavex, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06190717)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Phase 3 Interventional 466 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07321652)
Google-rated

Top-rated research centers in Lansing

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Michigan Cancer Research Consortium

1140 E Michigan Ave, Lansing, MI 48912
(517) 364-9402

CTSI (Clinical and Translational Sciences Institute)

909 Wilson Rd Ste B500, East Lansing, MI 48824

Professional Building | UM Health-Sparrow

★ 4.4
1200 E Michigan Ave, Lansing, MI 48912
(517) 364-1000
"Made an appointment last night for this morning. The kiosk at check in said to check with staff about my appointment. Nobody ever around in the lab u…"
— Curt Barnum, 1★

Hannah Technology Research Center

★ 4.1
4660 Hagadorn Rd, East Lansing, MI 48823
(517) 332-5606
"Visiting MSU Physician. It's a nice place, lots of parking"
— Angela Christine, 5★

MSU Center for Bioethics and Social Justice

965 Wilson Rd Rm A126, East Lansing, MI 48824
(517) 355-7550

College of Veterinary Medicine

★ 3.5
784 Wilson Rd G100, East Lansing, MI 48824
(517) 353-5420
"I can not say enough wonderful things about our experience. Every single person involved in our very emergent situation was so helpful and kind. Very…"
— Kristy Moore, 5★

Mid-West Center for Sleep Disorders Lansing

★ 4.1
3937 Patient Care Dr #102/103, Lansing, MI 48911
(517) 887-6733
"This place was so awesome, the staff made me feel so comfortable and set my heart at ease about all the equipment attached to me for the sleep study,…"
— Shaun Miller, 5★

Detroit Clinical Research Center

★ 5.0
30160 Orchard Lake Rd #110, Farmington Hills, MI 48334
(248) 737-5939

Rassel-Daigneault Holistic Health Center

★ 4.8
537 N Clippert St, Lansing, MI 48912
(517) 336-8880

Clinical trials in Lansing: what's recruiting

The Lansing area currently has 185 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lansing, the most active research areas are:

  • Cancer & Oncology16 studies
  • Immune & Skin4 studies
  • Heart & Vascular1 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Lansing, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lansing

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lansing participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Lansing safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Lansing, MI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Lansing?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Lansing?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Lansing.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Lansing typically complete one or two studies per year.

Paid clinical trials near Lansing

Other metros within reach

Flint, MI181 Ann Arbor, MI1,179 South Lyon, MI1,315 Kalamazoo, MI109 Grand Rapids, MI455 Toledo, OH209 Detroit, MI1,179 Fort Wayne, IN112

More of MI

South Lyon1,315 Detroit1,179 Ann Arbor1,179 Grand Rapids455 Flint181 Kalamazoo109 Muskegon61

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts